UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 13, 2004
BIOPHAN TECHNOLOGIES, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
NEVADA 0-26057 82-0507874
---------------------------- ------------- -------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
150 LUCIUS GORDON DRIVE, SUITE 215
WEST HENRIETTA, NEW YORK 14586
--------------------------------------- ---------
(Address of principal executive offices) (Zip code)
(585) 214-2441
-------------------------------
(Registrant's telephone number)
-2-
Item 9. Regulation FD Disclosure
On July 13, 2004, the Company held its Annual Stockholders Meeting and, in
addition to the conduct of regular business matters, announced that John
Lanzafame, former President of STS Polymers, which was acquired earlier this
year by Angiotech Pharmaceuticals (NasdaqNM:ANPI), is leading Biophan's efforts
related to the use of the Company's nanomagnetic particle coating technology for
drug delivery applications, including controlled drug release using
electromagnetic fields. A Powerpoint presentation provided by Mr. Lanzafame was
presented at the Meeting, and is available for viewing on the Company's website
at www.biophan.com/2004.php . The Company also announced that Nanoset, LLC, its
nanomagnetic particle technology partner, had filed several patents on the
technology, including a 540 page patent application filed two weeks prior to the
meeting. Biophan holds the worldwide exclusive license for medical applications
developed by Nanoset.
-3-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOPHAN TECHNOLOGIES, INC.
-----------------------------
(Registrant)
Date: July 19, 2004 /s/ Robert J. Wood
------------- ------------------------------
(Signature)
Robert J. Wood
CFO, Treasurer
(Principal Financial Officer)